TRAF4 and neoplasm: Based on our findings, the further study focuses on whether blocking TRAF4 combined with SRT treatment has a positive synergistic effect in promoting tumor regression and preventing tumor recurrence may be a clinically valuable research point that provides a potential management strategy for omCRC patients.